10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 273 filers reported holding 10X GENOMICS INC in Q4 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $56,106,656 | +5.7% | 2,884,661 | +104.0% | 0.27% | +11.6% |
| Q1 2024 | $53,072,074 | -38.1% | 1,414,124 | -7.7% | 0.24% | -37.8% |
| Q4 2023 | $85,696,697 | +35.0% | 1,531,392 | -0.5% | 0.39% | +16.5% |
| Q3 2023 | $63,476,655 | -43.6% | 1,538,828 | -23.6% | 0.33% | -38.7% |
| Q2 2023 | $112,537,814 | -19.9% | 2,015,362 | -20.0% | 0.54% | -27.1% |
| Q1 2023 | $140,555,820 | +51.4% | 2,519,373 | -1.1% | 0.75% | +39.6% |
| Q4 2022 | $92,852,764 | +25.1% | 2,548,100 | -2.2% | 0.54% | +21.8% |
| Q3 2022 | $74,210,000 | -37.5% | 2,605,677 | -0.7% | 0.44% | -32.0% |
| Q2 2022 | $118,699,000 | – | 2,623,190 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 2,106,757 | $117,894,122 | 100.00% |
| Blue Water Life Science Advisors, LP | 194,500 | $10,884,220 | 9.53% |
| Sands Capital Ventures, LLC | 481,770 | $26,959,849 | 7.50% |
| Meritech Capital Associates V L.L.C. | 494,236 | $27,657,447 | 6.73% |
| Decheng Capital LLC | 359,554 | $20,120,642 | 5.62% |
| Iron Triangle Partners LP | 479,374 | $26,825,769 | 3.47% |
| Brown Capital Management | 3,527,297 | $197,387,540 | 2.96% |
| Freshford Capital Management, LLC | 305,798 | $17,112,456 | 2.78% |
| SVB WEALTH LLC | 1,446,552 | $80,949,066 | 1.97% |
| Capital Impact Advisors, LLC | 23,594 | $1,320,320 | 1.74% |